Impact of Local Administration of Liposome Bupivacaine for Postsurgical Analgesia on Wound Healing: A Review of Data From Ten Prospective, Controlled Clinical Studies

Clinical Therapeutics

Volumn 35, Issue 3, 2013, Pages

  Baxter, Richard ^a   Bramlett, Kenneth ^b   Onel, Erol ^c   Daniels, Stephen ^d  

^a Plastic Surgery Clinic   (United States)

^b Alabama Orthopaedic Institute   (United States)

^c Pacira Pharmaceuticals Inc   (United States)

^d Premier Research   (United States)

Author keywords

Analgesic; Local anesthetic; Postsurgical pain; Wound infiltration

Indexed keywords

BUPIVACAINE; LIPOSOME BUPIVACAINE; LOCAL ANESTHETIC AGENT; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DRAINAGE; ADULT; ARTICLE; BREAST AUGMENTATION; BUNIONECTOMY; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EDEMA; ERYTHEMA; FEMALE; HEMORRHOIDECTOMY; HERNIOPLASTY; HUMAN; INGUINAL HERNIA; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; NEUROLOGIC DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SKIN INDURATION; TOTAL KNEE REPLACEMENT; WOUND HEALING;

EID: 84874989818     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2013.02.005     Document Type: Article

References (30)

1. Apfelbaum J.L. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2012, 116:248-273.
2. McGuire L., Heffner K., Glaser R., et al. Pain and wound healing in surgical patients. Ann Behav Med 2006, 31:165-172.
3. Jin F., Chung F. Multimodal analgesia for postoperative pain control. J Clin Anesth 2001, 13:524-539.
4. ® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 2011, 28:776-788.
5. Gorfine S.R., Onel E., Patou G., et al. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 2011, 54:1552-1559.
6. ® bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammoplasty: a randomized, double-blind, active-control study. Aesthet Surg J 2012, 32:69-76.
7. Haas E., Onel E., Miller H., et al. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg 2012, 78:574-581.
8. Bailie D.S., Ellenbecker T.S. Severe chondrolysis after shoulder arthroscopy: a case series. J Shoulder Elbow Surg 2009, 18:742-747.
9. Hansen B.P., Beck C.L., Beck E.P., et al. Postarthroscopic glenohumeral chondrolysis. Am J Sports Med 2007, 35:1628-1634.
10. Rapley J.H., Beavis R.C., Barber F.A. Glenohumeral chondrolysis after shoulder arthroscopy associated with continuous bupivacaine infusion. Arthroscopy 2009, 25:1367-1373.
11. Noyes F.R., Fleckenstein C.M., Barber-Westin S.D. The development of postoperative knee chondrolysis after intra-articular pain pump infusion of an anesthetic medication: a series of twenty-one cases. J Bone Joint Surg Am 2012, 94:1448-1457.
12. Bergese S.D., Ramamoorthy S., Patou G., et al. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res 2012, 5:107-116.
13. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1) International Conference on Harmonisation Working Group, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; June 10, 1996; Washington, DC, Accessed April 19, 2012. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf.
14. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects World Medical Association, Accessed April 19, 2012. http://www.wma.net/en/30publications/10policies/b3/17c.pdf.
15. Langford RM, Chappell GM, Karrasch JA. A single administration of DepoBupivacaine intraoperatively results in prolonged detectable plasma bupivacaine and analgesia in patients undergoing inguinal hernia repair. Presented at: Annual Postgraduate Assembly in Anesthesiology of the New York State Society of Anesthesiologists; December 12-16, 2008; New York, NY. Abstract P-9088.
16. White P.F., Schooley G.L., Ardeleanu M. Analgesia following a single administration of depobupivacaine intraoperatively in patients undergoing inguinal herniorrhaphy: preliminary dose-ranging studies. Anesth Analg 2009, 108(Suppl 3S). Abstract S-242.
17. Bramlett K., Onel E., Viscusi E.R., et al. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee 2012, 19:530-536.
18. Miller H, Terem TM, Kheladze K, Mosidze B. A single administration of DepoBupivacaine intraoperatively provides three-day analgesia and reduction in use of rescue opioids in patients undergoing hemorrhoidectomy. Presented at: Annual Meeting of the American Society of Colon and Rectal Surgeons; May 2- 6, 2009; Hollywood, Fla. Abstract.
19. Baryza M.J., Baryza G.A. The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil 1995, 16:535-538.
20. Minkowitz H.S., Onel E., Patronella C.K., et al. A two-year observational study assessing the safety of DepoFoam bupivacaine after augmentation mammaplasty. Aesthet Surg J 2012, 32:186-193.
21. Bagul A., Taha R., Metcalfe M.S., et al. Pre-incision infiltration of local anesthetic reduces postoperative pain with no effects on bruising and wound cosmesis after thyroid surgery. Thyroid 2005, 15:1245-1248.
22. Dere K., Sen H., Teksoz E., et al. The comparison of the effects of different doses of levobupivacaine infiltration on wound healing. J Invest Surg 2009, 22:112-116.
23. Dogan N., Ucok C., Korkmaz C., et al. The effects of articaine hydrochloride on wound healing: an experimental study. J Oral Maxillofac Surg 2003, 61:1467-1470.
24. Waite A., Gilliver S.C., Masterson G.R., et al. Clinically relevant doses of lidocaine and bupivacaine do not impair cutaneous wound healing in mice. Br J Anaesth 2010, 104:768-773.
25. Nechleba J., Rogers V., Cortina G., et al. Continuous intra-articular infusion of bupivacaine for postoperative pain following total knee arthroplasty. J Knee Surg 2005, 18:197-202.
26. Ratner B.D., Bryant S.J. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004, 6:41-75.
27. Karukonda S.R., Flynn T.C., Boh E.E., et al. The effects of drugs on wound healing-part II. Specific classes of drugs and their effect on healing wounds. Int J Dermatol 2000, 39:321-333.
28. Stratford A.F., Zoutman D.E., Davidson J.S. Effect of lidocaine and epinephrine on Staphylococcus aureus in a guinea pig model of surgical wound infection. Plast Reconstr Surg 2002, 110:1275-1279.
29. Tran D.T., Miller S.H., Buck D., et al. Potentiation of infection by epinephrine. Plast Reconstr Surg 1985, 76:933-934.
30. Barker W., Rodeheaver G.T., Edgerton M.T., et al. Damage to tissue defenses by a topical anesthetic agent. Ann Emerg Med 1982, 11:307-310.